Table 1 Baseline characteristics stratified according to the presence of chronic kidney disease on admission
Entire cohort N (%) | non-CKD patients N (%) | CKD patients N (%) | p-value | |
|---|---|---|---|---|
N | 944 | 754 | 190 | |
Female sex | 285 (30.2) | 205 (27.2) | 80 (42.1) | < 0.001 |
Age, mean (SD), y | 64.1 (12.3) | 62 (12.1) | 72.4 (9.1) | < 0.001 |
ACS | ||||
STEMI | 516 (54.7) | 417 (55.3) | 99 (52.1) | 0.43 |
NSTEMI | 237 (25.1) | 196 (26.0) | 41 (21.6) | 0.21 |
UAP | 191 (20.2) | 141 (18.7) | 50 (26.3) | 0.02 |
Management | ||||
Interventional | 707 (74.9) | 573 (76) | 134 (70.5) | 0.12 |
CABG | 57 (6) | 40 (5.3) | 17 (9) | 0.06 |
OMT | 180 (19.1) | 141 (18.7) | 39 (20.5) | 0.57 |
CVRF | ||||
Art. HTN | 631 (66.8) | 481 (63.8) | 150 (78.9) | < 0.001 |
Hyperlipidemia | 401 (42.5) | 318 (42.4) | 83 (43.7) | 0.71 |
Diabetes | 208 (22) | 144 (19.1) | 64 (33.7) | < 0.001 |
Smoking status | 300 (31.8) | 277 (36.7) | 23 (12.1) | < 0.001 |
Family history | 139 (14.7) | 119 (15.8) | 20 (10.5) | 0.07 |